gastroenterology

Coeliac disease may be eased by JAK inhibitor

The Janus kinase (JAK) inhibitor tofactitinib that is used to treat autoimmune diseases such as ulcerative colitis and rheumatoid arthritis may also have potential as a treatment for coeliac disease, according to gastroenterologists in  Europe. Clinicians in Belgium have found that a man using tofactitinib to treat alopecia also had remission in a his celiac ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic